 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
.svg){kind=small}
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Ritonavir.
|
Hit-and-run Edit
editThe quality of the text removed was not highly encyclopedic. "Delete now and ask questions never" could be attributed to style.
Text removed:
- Research that led to the drug's development was financed by a $3,500,000 federal grant through the National Institutes of Health (NIH) and over $200,000,000 by Abbott Labs. Most of the $200,000,000 figure cited by Abbott paid for clinical trials—despite NIH offering to pay for them—because Abbott was concerned about "public interest" responses to the high prices they projected Norvir would command.[1]
But to do the edit (deletion):
- On text which portrays a drug company in a negative light.
- Without discussion or debate.
- From an account identified only by an IP address.
- Where said IP address has only performed one "contribution": edit by 70.211.9.4 to date
- Using a revision comment that suggests some level of sophistication: removed statment [sic] supported only by reference to an advocacy group blog WP:QUESTIONABLE
Seems very suspicious to me that there are ulterior motives[2][3] , what do other people think? Thanks 96.26.79.253 (talk) 12:14, 5 July 2014 (UTC)
References
edit- ^ James Love (2004-06-03). "How much has the public invested in ritonavir, and how much has Abbott?". Essential Inventions. Retrieved 2008-05-06..
- ^ Newman, Lily Hay (17 June 2014). "Wikipedia Is Smoking Out Paid Editors". Slate/Future Tense. The Slate Group, a Graham Holdings Company. Retrieved 5 July 2014.
- ^ Ford, Sam (10 June 2014). "Narrowing the Chasm Between PR Professionals and Wikipedia". Harvard Business Review Blog Network. Harvard Business School Publishing. Retrieved 5 July 2012.
Abbott interview about polymorphs
editThere is a striking set of four interviews/presentations, whose transcripts are available here:
- https://web.archive.org/web/19991003043516/http://iapac.org/norvir/abt_sun.html
- https://web.archive.org/web/20020626132036/http://www.iapac.org/norvir/abt_byrn.html
- https://web.archive.org/web/20020626132855/http://www.iapac.org/norvir/abt_lichter.html
- https://web.archive.org/web/20020626133033/http://www.iapac.org/norvir/abt_dintruff.html
Parts of it were quoted in https://onlinelibrary.wiley.com/doi/full/10.1002/anie.201410356 including:
- A company’s size and the collective IQs of their scientists have no relationship to this problem.
But that paper didn't have a current source for the transcript, so I wanted to mention it here in case others are looking for it. JesseW, the juggling janitor 01:54, 16 May 2020 (UTC)
Sold{where}
editRitonavir (RTV), sold[where?] under the brand name Norvir, is an antiretroviral medication used along with other medications to treat HIV/AIDS.
I added the flag. The reader shouldn't have to finish the lead to puzzle out that it quite likely implies "sold globally", which I certainly can't add myself to resolve the flag, because I know nothing about this topic whatsoever. — MaxEnt 17:02, 5 November 2021 (UTC)